Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles
Georgios Mangioris(Mayo Clinic), Αναστασία Ζεκερίδου(Mayo Clinic), Eoin P. Flanagan, Vanda A. Lennon(Mayo Clinic), Bryce Kalei Chang(Mayo Clinic), John R. Mills(Mayo Clinic), Sean J. Pittock(Mayo Clinic), Þorvarður R. Hálfdánarson(Mayo Clinic), P. James B. Dyck(Mayo Clinic), Andrew McKeon(Mayo Clinic), Divyanshu Dubey(Université Claude Bernard Lyon 1)
Cited by 3
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k